InsiderSignal.AI

InsiderSignal.ai

KRRO - Korro Bio, Inc.

Insider Purchase by Florence Anthony A. Jr. (10%)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

5 days ago, Florence Anthony A. Jr., serving as 10% owner at Korro Bio, Inc. (KRRO), purchased 207,100 shares at $11.11 per share, for a total transaction value of $2,300,881.00. Following this transaction, Florence Anthony A. Jr. now holds 1,297,893 shares of KRRO.

This purchase represents a 19.00% increase in Florence Anthony A. Jr.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 10, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 12, 2026, 2 days after the trade was made.

Korro Bio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Florence Anthony A. Jr.

10%

Anthony A. Florence, Jr. is a venture capital executive serving as a 10% owner of SpyGlass Pharma, Inc. (SGP), a late-stage biopharmaceutical company developing sustained drug delivery systems for chronic eye conditions.[[1]](https://www.stocktitan.net/sec-filings/SGP/form-3-spy-glass-pharma-inc-initial-statement-of-beneficial-ownership-56d3baa805e0.html)[[4]](https://www.quiverquant.com/stock/SGP/insiders/) He filed a Form 3 reporting indirect holdings in multiple series of preferred stock convertible into over 2.5 million common shares, owned directly by New Enterprise Associates (NEA) funds, where he holds managing roles at their general partners.[[1]](https://www.stocktitan.net/sec-filings/SGP/form-3-spy-glass-pharma-inc-initial-statement-of-beneficial-ownership-56d3baa805e0.html) Florence recently participated in a directed share purchase of approximately 937,500 shares at $16 per share on February 9, 2026, alongside other insiders.[[3]](https://www.ainvest.com/news/spyglass-pharma-director-khan-bilal-arshad-buys-115000-shares-16-share-2602/)[[4]](https://www.quiverquant.com/stock/SGP/insiders/)[[8]](https://www.benzinga.com/quote/SGP/insider-trades) Florence is affiliated with New Enterprise Associates, a prominent venture capital firm, as indicated in SEC filings listing him among managing directors or partners who granted power of attorney for filings.[[2]](https://www.otcmarkets.com/filing/html?id=19120745&guid=n-3-kHvLeDQRLEh)[[9]](https://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13D++SpyGlass+Pharma,+Inc.++++++++++++++++++Filed+by:+New+Enterprise+Associates+17,+L.P./26002461.html) His address is listed as 104 5th Avenue, 19th Floor, New York, NY 10011.[[2]](https://www.otcmarkets.com/filing/html?id=19120745&guid=n-3-kHvLeDQRLEh) With an estimated net worth exceeding $3.4 billion as of early 2026, Florence has significant investments across public companies, including a director role at Robinhood.[[6]](https://www.gurufocus.com/insider/28655/florence-anthony-a.-jr.)

View full insider profile →

Trade Price

$11.11

Quantity

207,100

Total Value

$2,300,881.00

Shares Owned

1,297,893

Trade Date

Tuesday, March 10, 2026

5 days ago

SEC Filing Date

Thursday, March 12, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Korro Bio, Inc.

Company Overview

No company information available
View news mentioning KRRO

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4728359

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime